Remicade
Remicade (infliximab) is indicated for the treatment of Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, and Plaque Psoriasis. Remicade is administered as an intravenous infusion. Remicade blocks the action of the tumor necrosis factor-alpha (TNF-alpha) protein in your body. TNF-alpha is made by your body’s immune system. People with certain diseases have […]
Reclast
Reclast (sometimes called Zoledronate) is a bisphosphonate medications that alters bone formation and breakdown in the body. Reclast is used to treat or prevent osteoporosis caused by menopause or steroid use. This medicine also increases bone mass in men with osteoporosis. Reclast is for use when you have a high risk of bone fractures. Reclast […]
Soliris
Soliris is a first-in-class terminal complement inhibitor discovered, developed, and commercialized by Alexion. Soliris works by selectively inhibiting activation of specific proteins in the complement system (C5a and C5b), which play a role in the pathophysiology of multiple rare diseases. Soliris is indicated for: the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce […]
Skyrizi
Skyrizi is the first treatment for Crohn’s that works differently by specifically targeting the interleukin-23 (IL-23) protein, which is one of the key proteins responsible for inflammation. Skyrizi also treats moderately to severely active rheumatoid arthritis (RA) and active psoriatic arthritis. By targeting IL-23, SKYRIZI can help reduce the excess inflammation that may contribute to […]
Simponi Aria
Simponi Aria is a prescription medicine used to treat: Moderate to severe rheumatoid arthritis (RA) in adults, used in combination with methotrexate Active psoriatic arthritis (PsA) in people 2 years of age and older Active ankylosing spondylitis (AS) in adultsSimponi Aria targets, binds with, and blocks excess TNF-alpha (tumor necrosis factor-alpha), an underlying cause of […]
Cimzia
Cimzia is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used in adults to: – Lessen the signs and symptoms of moderately to severely active Crohn’s disease (CD) in adults who have not been helped enough by usual treatments– Treat moderately to severely active rheumatoid arthritis (RA)– Treat active psoriatic arthritis (PsA)– Treat […]
Cerezyme
Cerezyme is a hydrolytic lysosomal glucocerebrosidase-specific enzyme indicated for treatment of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease that results in one or more of the following conditions: anemia, thrombocytopenia, bone disease, hepatomegaly or splenomegaly. Gaucher disease is a rare, progressive, inherited, genetic condition that causes a […]
Cabenuva
Cabenuva is a 2-drug co-packaged product of cabotegravir and rilpivirine. It is indicated as a complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years of age and older and weighing at least 35kg to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA <50 copies/mL) with […]
Stelara IV
Stelara (ustekinumab) is a human interleukin-12 and -23 antagonist indicated for the treatment of: Moderate to severe plaque psoriasis (Ps) who are candidates for phototherapy or systemic therapyactive psoriatic arthritis (PsA), alone or in combination with methotrexate, moderately to severely active Crohn’s diseasemoderately to severely active ulcerative colitis. Resources Contact Us Administration Information Stelara treatment […]
Saphnelo
Saphnelo is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy. Saphnelo is the first and only SLE treatment to target type 1 interferon (IFN-1) activity. Based on three clinical studies, when added to your Lupus treatments, Saphnelo may help reduce disease activity and […]
